Regents of the University of California’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-37,500
| Closed | -$162K | – | 44 |
|
|
2021
Q4 | $162K | Hold |
37,500
| – | – | 0.02% | 40 |
|
|
2021
Q3 | $191K | Sell |
37,500
-37,500
| -50% | -$191K | 0.02% | 37 |
|
|
2021
Q2 | $475K | Hold |
75,000
| – | – | 0.06% | 29 |
|
|
2021
Q1 | $580K | Buy |
+75,000
| New | +$580K | 0.08% | 26 |
|
|
2017
Q3 | – | Sell |
-36,499
| Closed | -$566K | – | 22 |
|
|
2017
Q2 | $566K | Sell |
36,499
-34,085
| -48% | -$529K | 2.48% | 14 |
|
|
2017
Q1 | $1.22M | Buy |
70,584
+22,918
| +48% | +$396K | 5.97% | 6 |
|
|
2016
Q4 | $524K | Sell |
47,666
-23,700
| -33% | -$261K | 1.86% | 19 |
|
|
2016
Q3 | $1.12M | Hold |
71,366
| – | – | 3.2% | 11 |
|
|
2016
Q2 | $729K | Buy |
+71,366
| New | +$729K | 2.45% | 16 |
|